Added to YB: 2025-12-05
Pitch date: 2025-12-04
RMD [neutral]
ResMed Inc.
-9.09%
current return
Author Info
Best Anchor Stocks shares deep research on companies with long-term potential aThe Bear Cavend lower-than-average volatility. Sign up for the newsletter.
Company Info
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally.
Market Cap
$31.8B
Pitch Price
$252.96
Price Target
N/A
Dividend
1.20%
EV/EBITDA
14.50
P/E
21.13
EV/Sales
5.51
Sector
Health Care Equipment and Supplies
Category
N/A
Resmed (RMD): The Sleep 'Monopoly'
RMD (pass): Sleep apnea CPAP monopolist w/ 80%+ market share after Phillips recall. Faces headwinds from Apnimed's Phase III oral pill (46.8% AHI reduction vs 6.8% placebo, NDA filing 2026) & GLP-1 weight loss drugs potentially reducing severe cases. Trades 26x P/E despite growth decel.
Read full article (8 min)